-
My story is long but I’ll try to make it short. I was initially denied immunotherapy for my stage 3/4 melanoma. We started second line treatment of Braftovi/Mektovi for 4 months until I had a rare life threatening side effect. This landed me in the hospital for emergency surgery which induced a severe myasthenia flare. I have MUSK MG so my treatments are limited. 2 months later I had new abdominal growths so we started Nivolumab as I had nothing to lose. My physician team decided PLEX would be the best treatment for my MG while receiving immunotherapy. The Nivolumab wasn’t working so we added 4 treatments ipilumimab (Yervoy) to the Opdivo. I received PLEX and then the immunotherapy every 4 weeks. There was no evidence of disease after four months and I continued the PLEX and Opdivo for another few months. We then transitioned me back to Rituximab every 6 months and continued the Nivolumab (Opdivo) for another year. I continue to have no evidence of cancer on my scans. I was weaker and more fatigued during treatment but it did not induce a flare. I believe the cancer was attributing to my MG as I was having increased symptoms before the cancer was discovered.